Cibus Stock (NASDAQ:CBUS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$1.70

52W Range

$1.09 - $4.19

50D Avg

$1.50

200D Avg

$1.83

Market Cap

$82.33M

Avg Vol (3M)

$354.14K

Beta

1.65

Div Yield

-

CBUS Company Profile


Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

118

IPO Date

Jul 20, 2017

Website

CBUS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24
Reportable Segment$3.64M$4.26M

Fiscal year ends in Dec 25 | Currency in USD

CBUS Financial Summary


Dec 25Dec 24Dec 23
Revenue$3.64M$4.26M$1.82M
Operating Income$-97.53M$-258.40M$-318.88M
Net Income$-127.08M$-251.39M$-267.63M
EBITDA$-97.53M$-241.63M$-314.58M
Basic EPS$-2.78$-10.83$-25.95
Diluted EPS$-2.78$-10.83$-25.95

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 14, 26 | 4:30 PM
Q4 25Mar 17, 26 | 4:30 PM
Q3 25Nov 13, 25 | 4:30 PM

Peer Comparison


TickerCompany
MNOVMediciNova, Inc.
CAMPCAMP4 Therapeutics Corporation
RPTXRepare Therapeutics Inc.
PMVPPMV Pharmaceuticals, Inc.
BMEABiomea Fusion, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
IMUXImmunic, Inc.
RLMDRelmada Therapeutics, Inc.
VXRTVaxart, Inc.
UNCYUnicycive Therapeutics, Inc.